January 2023 guidance from FDA on dosages in oncology provides further context on expectations with Project Optimus.
Julie Bullock, PharmD
Advertisement
Articles by Julie Bullock, PharmD
How the use of M&S in cancer trials from the outset can help address those critical “what if?” scenarios and accelerate oncology drug development.
Advertisement
Latest Updated Articles
- FDA’s Project Optimus Guidance: Highlights and Tips for Success for Oncology Drug Developers
Published: April 24th 2023 | Updated:
Leveraging Modeling & Simulation in OncologyPublished: September 1st 2018 | Updated:
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
ACT Brief: AI, Equity, and Innovation Drive Clinical Research Forward
2
Reducing Site Burden Through Better Technology Integration in Clinical Trials
3
Imfinzi Regimen Demonstrates 22% Survival Benefit in Early Gastric and GEJ Cancer
4
Broad Survival Benefit from MATTERHORN Trial Highlights New Approach to Biomarker Use
5
.png "BioPharm International")
.png "Pharmaceutical Commerce"){kind=logo}
.png "Turbo Machinery Magazine")
.png){kind=spacer}
